Singaporean (SGX) Pharma Industry Analysis
UpdatedMay 30, 2023
DataAggregated Company Financials
Companies5
- 7D-1.9%
- 3M40.4%
- 1Y53.1%
- YTD59.1%
The Pharma industry has stayed flat over the last week. As for the the longer term, the industry is up 55% over the past 12 months. Looking forward, earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Singaporean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 May 2023 | S$7.1b | S$1.6b | S$291.8m | 11.7x | 24.3x | 4.6x |
| Thu, 27 Apr 2023 | S$6.0b | S$1.5b | S$267.8m | 12.9x | 22.6x | 3.9x |
| Sat, 25 Mar 2023 | S$5.4b | S$1.4b | S$265.0m | 8.8x | 20.3x | 3.9x |
| Mon, 20 Feb 2023 | S$5.8b | S$1.4b | S$252.0m | 9.7x | 23.2x | 4.2x |
| Wed, 18 Jan 2023 | S$5.1b | S$1.4b | S$264.8m | 8.7x | 19.2x | 3.6x |
| Fri, 16 Dec 2022 | S$4.9b | S$1.4b | S$261.2m | 8.2x | 18.7x | 3.6x |
| Sun, 13 Nov 2022 | S$4.9b | S$1.3b | S$255.8m | 10.8x | 19x | 3.6x |
| Tue, 11 Oct 2022 | S$4.4b | S$1.3b | S$247.1m | 10.7x | 17.7x | 3.3x |
| Thu, 08 Sep 2022 | S$4.9b | S$1.4b | S$249.9m | 10.8x | 19.5x | 3.6x |
| Sat, 06 Aug 2022 | S$4.8b | S$1.3b | S$228.5m | 10.1x | 20.9x | 3.6x |
| Mon, 04 Jul 2022 | S$5.0b | S$1.3b | S$229.3m | 10.4x | 21.7x | 3.7x |
| Wed, 01 Jun 2022 | S$4.9b | S$1.3b | S$228.9m | 10.8x | 21.5x | 3.7x |
| Fri, 29 Apr 2022 | S$4.6b | S$1.3b | S$232.7m | 12.5x | 19.9x | 3.4x |
| Sun, 27 Mar 2022 | S$5.5b | S$1.4b | S$248.4m | 12x | 22x | 3.9x |
| Tue, 22 Feb 2022 | S$5.5b | S$1.4b | S$219.7m | 14.6x | 24.9x | 4x |
| Thu, 20 Jan 2022 | S$5.7b | S$1.3b | S$212.7m | 14.9x | 26.7x | 4.2x |
| Sat, 18 Dec 2021 | S$5.3b | S$1.3b | S$212.4m | 14.1x | 25x | 4x |
| Mon, 15 Nov 2021 | S$5.4b | S$1.3b | S$211.9m | 14.8x | 25.3x | 4x |
| Wed, 13 Oct 2021 | S$5.4b | S$1.3b | S$203.4m | 14.5x | 26.3x | 4.1x |
| Fri, 10 Sep 2021 | S$5.7b | S$1.3b | S$203.2m | 22.4x | 28.2x | 4.4x |
| Sun, 08 Aug 2021 | S$5.8b | S$1.3b | S$203.2m | 20.4x | 28.4x | 4.4x |
| Sat, 01 May 2021 | S$5.5b | S$1.3b | S$205.8m | 21.6x | 26.8x | 4.3x |
| Tue, 02 Feb 2021 | S$4.5b | S$1.3b | S$218.6m | 16.7x | 20.4x | 3.5x |
| Fri, 06 Nov 2020 | S$3.9b | S$1.3b | S$210.7m | 16.8x | 18.4x | 3.1x |
| Mon, 10 Aug 2020 | S$4.1b | S$1.3b | S$239.9m | 20.4x | 17.3x | 3.3x |
Price to Earnings Ratio
13.7x
Current Industry PE
- Investors are optimistic on the Singaporean Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 24.5x which is higher than its 3-year average PE of 21.9x.
- The 3-year average PS ratio of 3.8x is lower than the industry's current PS ratio of 4.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Singaporean Healthcare industry?
| SG Market | -0.86% | |
| Healthcare | -1.46% | |
| Pharma | -1.95% | |
| Pharma | -1.95% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 42C iX Biopharma | S$0.095 | 4.4% +S$3.1m | -46.0% | PS19.5x | |
| BFK Pharmesis International | S$0.14 | 4.3% +S$165.6k | 68.6% | PS0.4x |